Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least?

Published:2016-07 Issue:1 Volume:1376 Page:5-13
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Pazianas Michael¹,Abrahamsen Bo²³

Affiliation:

1. Oxford University Institute of Musculoskeletal Sciences; Oxford United Kingdom

2. Odense Patient Data Explorative Network; University of Southern Denmark and Odense University Hospital; Odense Denmark

3. Department of Medicine; Holbaek Hospital; Holbaek Denmark

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.13166/fullpdf

Reference41 articles.

1. Osteoclast differentiation and activation;Boyle;Nature,2003

2. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate;Ettinger;J. Bone Miner. Res.,2004

3. Tsai , J. et al 2015

4. Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis;Pazianas;Ther. Clin. Risk Manag.,2010

5. Denosumab for prevention of fractures in postmenopausal women with osteoporosis;Cummings;N. Engl. J. Med.,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Insights and Therapeutic Strategies in Osteoporosis: A Comprehensive Review;Biomedicines;2024-07-23

2. Enhancing Osteoblast Differentiation from Adipose-Derived Stem Cells Using Hydrogels and Photobiomodulation: Overcoming In Vitro Limitations for Osteoporosis Treatment;Current Issues in Molecular Biology;2024-06-25

3. Urolithin A attenuates osteoclast differentiation and compensates for ovariectomy-induced bone loss in mice by inhibiting PI3K/AKT/mTOR signaling pathway;Phytomedicine Plus;2024-02

4. Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss;Nutrients;2023-02-12

5. Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34);JBMR Plus;2023-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3